The epidemiology of attention-deficit/hyperactivity disorder (ADHD): A public health view

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 8, Issue 3, 2002, Pages 162-170

  Rowland, Andrew S ^a,d   Lesesne, Catherine A ^b   Abramowitz, Ann J ^c  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Anxiety disorders; Attention Deficit Disorder with Hyperactivity; Comorbidity; Conduct disorder; Diagnosis; Drug therapy; Risk factors

Indexed keywords

AGE; ALCOHOL ABUSE; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; CHILD; CHILDHOOD DISEASE; COMORBIDITY; CONDUCT DISORDER; ENVIRONMENTAL FACTOR; GENDER; GENETIC LINKAGE; HUMAN; LEARNING DISORDER; MENTAL HEALTH SERVICE; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; RACE; REVIEW; SMOKING; SOCIAL STATUS; SUBSTANCE ABUSE; SYMPTOMATOLOGY;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DEVELOPMENTAL DISABILITIES; DISEASE PROGRESSION; HEALTH SERVICES; HUMANS; PREVALENCE; RISK FACTORS; RISK-TAKING; TERMINOLOGY;

EID: 0036953519     PISSN: 10804013     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrdd.10036     Document Type: Review

References (74)

1. Abikoff H, Courtney M, Pelham WE, et al. 1993. Teachers' ratings of disruptive behaviors: the influence of halo effects. J Abnorm Child Psychol 21:519-533.
2. ADHD Molecular Genetics Network. 2000. Collaborative possibilities for molecular genetic studies of attention deficit hyperactivity disorder: report from an international conference. Am J Medical Genetics 96:251-257.
3. American Academy of Pediatrics. 2000. Clinical practice guideline. Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 105:1158-1170.
4. American Psychiatric Association. 1994. Attention-deficit and disruptive behavior disorders. Washington DC: American Psychiatric Association Press 4:78-85.
5. American Psychiatric Association. 1997. Practice parameters for the assessment and treatment of children, adolescent and adults with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 36:085S-121S.
6. Anderson JC. 1996. Is childhood hyperactivity the product of western culture? Lancet 348:73-74.
7. August GJ, Realmuto GM, MacDonald AW, et al. 1996. Prevalence of ADHD and comorbid disorders among elementary school children screened for disruptive behavior. J Abnorm Child Psychol 24:571-595.
8. Barkley RA, Murphy KR, Kwasnik D. 1996. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics 98:1089-1095.
9. Barkley RA, Biederman J. 1997. Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 36:1204-1210.
10. Barkley RA. 1998. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment. Second Edition. New York: Guilford.
11. Barkley RA. 2000. Genetics of childhood disorders: ADHD, Part 1: the executive functions and ADHD. J Am Acad Child Adolesc Psychiatry 39:1064-1068.
12. Bellinger DC, Leviton A, Allred E, et al. 1994. Pre- and postnatal lead exposure and behavior problems in school-aged children. Environ Res 66:12-30.
13. Bellinger DC. 1995. Interpreting the literature on lead and child development: the neglected role of the experimental system. Neurotoxicol Teratol 17:201-212.
14. Biederman J, Newcorn J, Sprich S. 1991. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 148:564-577.
15. Biederman J, Faraone SV, Keenan K, et al. 1992. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Arch Gen Psychiatry 49:728-738.
16. Biederman J, Faraone S, Milberger S, et al. 1996. A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry 53:437-446.
17. Boyle MH, Offord DR, Hofmann HG, et al. 1987. Ontario child health study: I. methodology. Arch Gen Psychiatry 44:826-831.
18. Boyle MH, Offord DR, Racine Y, et al. 1996. Identifying thresholds for classifying childhood psychiatric disorder: issues and prospects. J Am Acad Child Adolesc Psychiatry 35:1440-1448.
19. Botting N, Powls A, Cooke RWI. 1997. Attention deficit hyperactivity disorder and other psychiatric outcomes in very low birthweight children at 12 years. J Child Psychol Psychiat 38:931-941.
20. Breslau N. 1995. Psychiatric sequelae of low birth weight. Epidemiologic Reviews 17:96-106.
21. Breslau N, Brown GG, DelDotto JE, et al. 1996. Psychiatric Sequelae of low birth weight at 6 years of age. J Abnorm Child Psychol 24:385-400.
22. Brown RT, Freeman WS, Perrin JM, et al. 2001. Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics 107:e43.
23. Bussing R, Zima BT, Belin TR. 1998. Variations in ADHD treatment among special education students. J Am Acad Child Adolesc Psychiatry 37:968-976.
24. Cantwell DP. 1996. Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 35:978-987.
25. Castellanos FX. 1997. Toward a pathophysiology of attention-deficit/hyperactivity disorder. Clinical Pediatrics 36:381-393.
26. Castellanos FX. 2001. Neuroimaging studies of ADHD. In: Solanto MV, et al., eds. Stimulant drugs and ADHD: basic and clinical neuroscience. Oxford. Oxford University Press, 243-258.
27. Curran S, Newman S, Taylor E, et al. 2000. Hypescheme: an operational criteria checklist and minimum data set for molecular genetic studies of attention deficit and hyperactivity disorders. Am J of Medical Genetics 96:244-250.
28. Denckla MB. 1992. Commentary: the myth of ADHD. J Child Neurol 7:458-461.
29. DiScala C, Lescohier I, Barthel M, et al. 1998. Injuries to children with attention deficit hyperactivity disorder. Pediatrics 102:1415-1421.
30. Elia J, Ambrosini PJ, Rappoport JL. 1999. Treatment of attention-deficit-hyperactivity disorder. N Engl J Med 11:780-788.
31. Fergusson DM, Fergusson JE, Horwood et al. 1988. A longitudinal study of dentine lead levels, intelligence, school performance and behavior: part III. dentine lead levels and attention/activity. J Child Psychol Psychiat 29: 811-824.
32. Fergusson DM, Lynskey MT, Horwood LJ. 1997. Attentional difficulties in middle childhood and psychosocial outcomes in young adulthood. J Child Psychol Psychiat 38:633-644.
33. Garland AF, Hough RL, McCabe KM, et al. 2001. Prevalence of psychiatric disorders in youths across five sectors of care. J Am Acad Child Adolesc Psychiatry 40:409-418.
34. Goldman LS, Bezman RJ, Siantetz PJ, et al. 1998. Diagnosis and treatment of Attention-deficit/ hyperactivity disorder in children and adolescents. JAMA 279:1100-1107.
35. Goodman R, Stevenson J. 1989. A twin study of hyperactivity: II. the aetiological role of genes, family relationships and perinatal adversity. J Child Psychol Psychiat 30:691-709.
36. Gordon M, Diniro D, Mettelman B. 1988. Effect upon outcome of nuances in selection criteria for ADHD/hyperactivity. Psychol Rep 62: 539-544.
37. Greene RW. 1996, Students with attention-deficit hyperactivity disorders and their teachers: implications of a goodness-of-fit perspective. Advances in Clinical Child Psychology 18: 205-230.
38. Guevara J, Lozano P, Wickizer T, et al. 2001. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics 108:71-78.
39. Halperin JM, Newcorn JH, Schwartz ST, et al. 1993. Plasma catecholamine metabolite levels in ADHD boys with and without reading disabilities. J Clin Child Psycol 22:219-225.
40. Hoagwood K, Jensen PS, Feil M, et al. 2000. Medication management of stimulants in pediatric practice settings: a national perspective. J Dev Behav Pediatr 21:322-331.
41. Jensen PS, Martin D, Cantwell DP. 1997. Comorbidity in ADHD: implications for research, practice and DSM-V. J Am Acad Child Adolesc Psychiatry 36:1065-1079.
42. Jensen PS, Brooks-Gunn J, Graber JA. 1999. Dimensional scales and diagnostic categories: constructing crosswalks for child psychopathology assessments. J Am Acad Child Adolesc Psychiatry 38:118-120.
43. Lambert NM, Hartsough CS. 1998. Prospective study of tobacco of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil 31: 533-544.
44. LeFever GB, Dawson KV, Morrow A. 1999. The extent of drug therapy for attention deficithyperactivity disorder among children in public schools. Am J Public Health 89:1359-1364.
45. Lou HC. 1996. Etiology and pathogenesis of attention-deficit/hyperactivity disorder (ADHD): significance of prematurity and perinatal hypoxic-haemodynamic encephalopathy. Acta Pediatr 85:1266-1271.
46. Mannuzza S, Klein RG, Bonagura N, et al. 1991. Hyperactive boys almost grown up v. replication of psychiatric status. Arch Gen Psychiatry 48:77-83.
47. Mannuzza S, Klein RG, Bessler A. 1993. Adult outcome of hyperactive boys. Arch Gen Psychiatry 50:565-576.
48. Milberger S, Biedennan J, Faraone SV, et al. 1996. Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children? Am J Psychiatry 153:1138-1142.
49. Mitis EM, McKay KE, Schulz KP, et al. 2000. Parent-teacher concordance for DSM-IV attention-deficit/hyperactivity disorder in a clinic-referred sample. J Am Acad Child Adolesc Psychiatry 38:308-313.
50. MTA Cooperative Group. 1999a. A 14-month randomized clinical trial of treatment scrategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1073-1086.
51. MTA Cooperative Group. 1999b. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1088-1096.
52. Needleman HL, Gunnoe C, Leviton A, et al. 1979. Deficits in psychologic and classroom performance of children with elevated dentine lead levels. N Engl J Med 300:689-695.
53. Offord DR, Boyle MH, Szatmari P, et al. 1987. Ontario Child Health Study II. Six-month prevalence of disorder and rates of service utilization. Arch Gen Psychiatry 44:832-836.
54. Paule MG, Rowland AS, Ferguson SA, et al. 2000. Attention deficit/hyperactivity disorder: characteristics, interventions, models. Neurotoxicology and Teratology 22:631-651.
55. Pirkle JL, Brody DJ, Gunter EW, et al. 1994. The decline of blood lead levels in the United States: the National Health and Nutrition Surveys (NHANES). JAMA 272:284-291.
56. Pliszka SR, Maas JW, Javors MA, et al. 1994. Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 33:1165-1173.
57. Rice DC. 1996. Behavioral effects of lead: commonalities between experimental and epidenuologic data. Environ Hlth Perspect 104: 337-351.
58. Rowe DC, Stever C, Giedinghagen LN, et al. 1998. Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Mol Psychiatry 5:419-426.
59. Rowland AS, Umbach DM, Catoe KE, et al. 2001. Studying the epidemiology of Attention-Deficit/Hyperactivity Disorder: screening method and pilot results. Can J Psychiatry 46:931-940.
60. Rowland AS, Umbach DM, Stallone L, et al. 2002. Prevalence of Medication treatment for Attendon-Deficit/Hyperactivity Disorder among Elementary School Children, Johnston County NC. Am J Public Health 92:231-234.
61. Safer DJ, Zito JM, Fine EM. 1996. Increased methylphenidate usage for attention deficit disorder in the 1990's. Pediatrics 98:1084-1088.
62. Sandberg S, Barton J. 1996. Historical development. In: Sandberg S, ed. Hyperactivity disorders of childhood. Cambridge: Cambridge University Press, pp. 1-25.
63. Shaffer D. 1994. Attention deficit hyperactivity disorder in adults. Am J Psychiatry 151:633-638.
64. Shaywitz BA, Shaywitz SE. 1991. Comorbidity: a critical issue in attention deficit disorder. J Child Neurol 6:S13-S20.
65. Swanson J, Deutsh C, Cantwell D, et al. 2001. Genes and attention-deficit hyperactivity disorder. Clinical Neuroscience Research 1:207-216.
66. Szatmari P, Offord DR, Boyle MH. 1989. Ontario child health study: prevalence of attention deficit disorder with hyperactivity. J Child Psychol Psychiat 30:219-30.
67. Taylor E, Sandberg S, Thorley G, et al. 1991. The epidemiology of childhood hyperactivity. Maudsley manuscripts; 33. Oxford: Oxford University Press.
68. Verloove-Vanhorick SP, Veen S, Ens-Dokkum MH, et al. 1994. Sex difference in disability and handicap at five years of age in children born at very short duration. Pediatrics 93: 576-579.
69. Waldman ID, Rhee SH. 2002. Behavioral and molecular genetic studies of ADHD. (in press).
70. Waldman ID, Rowe DC, Abramowitz A, et al. 1998. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet 6:1767-1776.
71. Wasserman RC, Kelleher KJ, Bocian A, et al. 1999. Identification of attentional and hyperactivity problems in primary care: a report from pediatric research in office settings and the ambulatory sentinel practice network. Pediatrics 103:e38.
72. Wells KC, Pelham WE, Kotkin RA, et al. 2000. Psychosocial treatment strategies in theMTA study: Rationale, methods, and critical issues in design and implementation. Journal of Abnormal Child Psychology 28:483-505.
73. Weinberg WA, Brumback RA. 1992. The myth of attention deficit-hyperactivity disorder: symptoms resulting from multiple causes. J Child Neurol 7:431-445.
74. Zametkin AJ, Ernst M. 1999. Problems in the management of attention-deficit-hyperactivity disorder. N Engl J Med 340:40-46.